Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TScan Therapeutics (TCRX) Times Interest Earned (2022 - 2025)

TScan Therapeutics (TCRX) has disclosed Times Interest Earned for 4 consecutive years, with -$33.99 as the latest value for Q4 2025.

  • Quarterly Times Interest Earned rose 27.42% to -$33.99 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$49.05 through Dec 2025, down 32.9% year-over-year, with the annual reading at -$49.05 for FY2025, 32.9% down from the prior year.
  • Times Interest Earned for Q4 2025 was -$33.99 at TScan Therapeutics, up from -$53.01 in the prior quarter.
  • The five-year high for Times Interest Earned was -$19.13 in Q4 2022, with the low at -$82.48 in Q3 2022.
  • Average Times Interest Earned over 4 years is -$39.07, with a median of -$34.02 recorded in 2024.
  • The sharpest move saw Times Interest Earned skyrocketed 69.44% in 2023, then plummeted 86.81% in 2024.
  • Over 4 years, Times Interest Earned stood at -$19.13 in 2022, then tumbled by 31.05% to -$25.07 in 2023, then crashed by 86.81% to -$46.83 in 2024, then rose by 27.42% to -$33.99 in 2025.
  • According to Business Quant data, Times Interest Earned over the past three periods came in at -$33.99, -$53.01, and -$56.1 for Q4 2025, Q3 2025, and Q2 2025 respectively.